On the trail of new strategies to treat conjunctivitis or dry eye disease with specialized pro-resolving mediators ?
SPM are Omega-3 derived lipids that activate biological defense mechanisms as inflammation resolution.
In this recent publication, Olsen et al. report how maresin 1(MaR1) regulates tear film mucin levels by controlling [Ca2+] levels. These findings suggest that MaR1 or its mimetic analogs could be a novel treatment for different inflammatory diseases spanning from allergic conjunctivitis to dry eye disease.
Here you can find more information about this study : click here
You need to evaluate the efficiency of your new ingredients on well being and health? Let’s have a chat on your projects!